Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent Jefferies in the offering. Vaccitech plc executed an at-the-marketing offering program of its American depositary shares representing its ordinary shares under...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent in the offering. RxSight, Inc. announced its shares of common stock for up to an aggregate amount of $50 million....
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised TransMedics, while Davis Polk advised representatives of the underwriters in the offering. TransMedics Group, Inc. executed its $150 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
Cravath represented Canadian National Railway Company in the offering, while Davis Polk & Wardwell represented the underwriters. Canadian National Railway Company executed its $1.5 billion registered senior...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Jefferies, the sole book-running manager, in the offering. Infinera Corporation executed its offering of $373.75 million aggregate principal amount of 3.75% convertible senior...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Intel, while Davis Polk & Wardwell advised the underwriters on the offering. Intel Corporation executed the offering consisting of $1.25 billion aggregate principal...
You must be a Standard 1 Year member to access this content.
Davis Polk advised TruArc Partners on the deal, while Dentons Cohen & Grigsby advised Molded Devices. TruArc Partners, LP announced its acquisition of Molded Devices, Inc....
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett LLP advised Covalto on the deal. Davis Polk & Wardwell LLP represented LIV Capital Acquisition Corp. II in the transaction. Covalto Ltd. announced...
You must be a Standard 1 Year member to access this content.
Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal. DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it...
You must be a Standard 1 Year member to access this content.
Salaverri, Burgio & Wetzler Malbrán and Cleary Gottlieb Steen & Hamilton advised Pampa Energia on the transaction. Bruchou & Funes de Rioja and Davis Polk &...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Texas Instruments, while Simpson Thacher represented BofA Securities, Inc., Citigroup Global Markets Inc., U.S. Bancorp Investments, Inc. in the offering. Texas Instruments Incorporated...
You must be a Standard 1 Year member to access this content.
